E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: a phase II clinical trialJan Philipp Bewersdorf,Maximilian Stahl,Justin Taylor,Xiaoli Mi,Namrata Sonia Chandhok,Justin Watts,Andriy Derkach, Mateusz Wysocki,Sydney X. Lu,Jessie Bourcier,Simon J. Hogg,Jahan Rahman,Sana Chaudhry,Tulasigeri M. Totiger,Omar Abdel-Wahab,Eytan M. SteinLeukemia(2023)引用 0|浏览10暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要